Back to School: How biopharma can reboot drug development. Access exclusive analysis here

VLP influenza vaccine: Interim Phase I/IIa data

Interim data from a double-blind, placebo-controlled, U.S. Phase I/IIa trial (H5N1 VLP-1) in

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE